Torrent Pharma

ICICI Securities recommended hold rating on Torrent Pharma with a target price of Rs 3530 in its research report dated July 29, 2025.

Torrent Pharma Q1 net profit up 20% at Rs 548 crore

The company's India revenues rose by 11% YoY to Rs 1,811 crore in the April-June period.

Hold Torrent Pharma; target of Rs 3500: ICICI Securities

ICICI Securities recommended hold rating on Torrent Pharma with a target price of Rs 3500 in its research report dated July 01, 2025.

Gainers & Losers: Top 10 stocks that moved the most on June 30

At close, the Sensex was down 452.44 points or 0.54 percent at 83,606.46, and the Nifty was down 124.00 points or 0.48 percent at 25,513.80. About 2,151 shares advanced, 1,538 shares declined, and 133 shares unchanged.

Neutral Torrent Pharma; target of Rs 3430: Motilal Oswal

Motilal Oswal recommended Neutral rating on Torrent Pharma with a target price of Rs 3430 in its research report dated June 30, 2025.

Quick Take: Torrent Pharma puts the money where its heart is

Torrent’s India business has been outperforming the domestic market

Torrent Pharma shares rise 4% after Rs 25,689-crore JB Chemicals deal; HSBC maintains buy

Torrent Pharma share price: The deal is expected to strengthen Torrent's market share in the Indian pharmaceutical market and diversify its platform into contract development and manufacturing.

Torrent Pharma to acquire controlling stake in JB Pharma from KKR at Rs 25,689 crore valuation

The transaction between Torrent and JB Pharma will unfold in two distinct phases

Torrent Pharma revives talks to acquire KKR’s stake in JB Pharma; deal expected soon

KKR’s stake is worth approximately Rs 13,400 crore considering the J B Pharma stock’s closing price of Rs 1,802.9 per share on June 27.

Neutral Torrent Pharma; target of Rs 3410: Motilal Oswal

Motilal Oswal recommended Neutral rating on Torrent Pharma with a target price of Rs 3410 in its research report dated January 25, 2025.

Torrent Pharma's Q3 net profit jumps 14% to Rs 503 crore; declares Rs 26/share interim dividend

The pharmaceutical firm’s net profit stood at Rs 453 crore in the September quarter, the stock filing showed

Q3 Results 2025 LIVE: IndiGo will have 40 planes with business class seats by the end of 2025

Earlier yesterday, UltraTech Cement, Dr Reddy’s Labs, Hindustan Petroleum, Mphasis, Zee, Indus Towers, Adani Green Energy, Adani Energy Solutions, Cyient Limited, Mankind Pharma and United Spirits announced their Q3 results.

Torrent Pharma strengthens anti-diabetes portfolio with acquisition of three brands from Boehringer

"The acquisition is expected to be completed in March 2025. Torrent has been marketing these brands since 2022 as part of an existing co-marketing agreement with Boehringer Ingelheim India," the company said in a statement.

Torrent Pharma shares rise after USFDA closes inspection with 'Voluntary Action' classification

The inspection was conducted by USFDA for Torrent's manufacturing facility at Pithampur, Madhya Pradesh between September 16-20, 2024.

Torrent Pharma stock drops 4% as promoter likely pares stake in Rs 3,239 cr block deal

As much as 1.04 crore shares, making up a 3.1 percent stake in Torrent Pharma changed hands at an over 3 percent discount from the stock's previous closing price.

Torrent Pharma promoters likely to sell shares worth up to Rs 3,000 cr via block deals: Reports

The shares are likely to be sold at a floor price of Rs 3022.7 apiece, which is at a nearly six percent discount to current market price

Torrent Pharma shares slip after CDSCO says Shelcal 500 fails its quality test

The pharma major has refuted the findings, clarifying that a batch of Shelcal 500 drug that failed the CDSCO test has not been manufactured by the company,